Clinical Trial Update: Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hormone therapy with or without docetaxel and estramustine in locally advanced or high-risk relapsing prostate cancer completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Estramustine (estramustine)

Snippet

Sponsor: UNICANCER | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED